Francesca Pentimalli

8.1k total citations
120 papers, 3.8k citations indexed

About

Francesca Pentimalli is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Francesca Pentimalli has authored 120 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 48 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Francesca Pentimalli's work include Cancer-related Molecular Pathways (25 papers), Ubiquitin and proteasome pathways (13 papers) and Occupational and environmental lung diseases (12 papers). Francesca Pentimalli is often cited by papers focused on Cancer-related Molecular Pathways (25 papers), Ubiquitin and proteasome pathways (13 papers) and Occupational and environmental lung diseases (12 papers). Francesca Pentimalli collaborates with scholars based in Italy, United States and United Kingdom. Francesca Pentimalli's co-authors include Antonio Giordano, Alfredo Fusco, Paola Indovina, Carlo M. Croce, Monica Fedele, Gennaro Chiappetta, Giuseppe Viglietto, Iris Maria Forte, Gustavo Baldassarre and Francesco Trapasso and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Francesca Pentimalli

116 papers receiving 3.7k citations

Peers

Francesca Pentimalli
Bassem R. Haddad United States
Yun‐Yong Park South Korea
Meiju Ji China
Scott D. Cramer United States
Sankar Addya United States
Francesca Pentimalli
Citations per year, relative to Francesca Pentimalli Francesca Pentimalli (= 1×) peers Manuela Gariboldi

Countries citing papers authored by Francesca Pentimalli

Since Specialization
Citations

This map shows the geographic impact of Francesca Pentimalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Pentimalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Pentimalli more than expected).

Fields of papers citing papers by Francesca Pentimalli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Pentimalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Pentimalli. The network helps show where Francesca Pentimalli may publish in the future.

Co-authorship network of co-authors of Francesca Pentimalli

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Pentimalli. A scholar is included among the top collaborators of Francesca Pentimalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Pentimalli. Francesca Pentimalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mauro, Annabella Di, Mariachiara Santorsola, Giovanni Savarese, et al.. (2024). High tumor mutational burden assessed through next-generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patients. Journal of Translational Medicine. 22(1). 1107–1107. 3 indexed citations
2.
Fiore, Riccardo Di, Rosa Drago‐Ferrante, Yashwanth Subbannayya, et al.. (2023). The Role of FBXW7 in Gynecologic Malignancies. Cells. 12(10). 1415–1415. 10 indexed citations
4.
Iannuzzi, Carmelina Antonella, et al.. (2021). RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways. Cancers. 13(19). 5025–5025. 9 indexed citations
5.
Forte, Iris Maria, Paola Indovina, Serena Montagnaro, et al.. (2021). The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach. Viruses. 13(12). 2458–2458. 15 indexed citations
6.
Fiore, Riccardo Di, Ana Félix, Sharon O’Toole, et al.. (2021). An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma. International Journal of Molecular Sciences. 22(12). 6506–6506. 9 indexed citations
7.
Fiore, Riccardo Di, Rosa Drago‐Ferrante, Ana Félix, et al.. (2021). LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?. International Journal of Molecular Sciences. 22(15). 7829–7829. 12 indexed citations
8.
Indovina, Paola, Iris Maria Forte, Francesca Pentimalli, & Antonio Giordano. (2020). Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade. Cancers. 12(7). 1866–1866. 7 indexed citations
9.
Indovina, Paola, Eliseo Mattioli, Iris Maria Forte, et al.. (2020). Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma. Cell Death and Disease. 11(10). 867–867. 2 indexed citations
10.
Indovina, Paola, Eliseo Mattioli, Iris Maria Forte, et al.. (2020). P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma. Cell Death and Disease. 11(9). 748–748. 33 indexed citations
11.
Correale, Pierpaolo, Luciano Mutti, Francesca Pentimalli, et al.. (2020). HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy. International Journal of Molecular Sciences. 21(15). 5205–5205. 66 indexed citations
12.
Iannuzzi, Carmelina Antonella, Paola Indovina, Iris Maria Forte, et al.. (2020). Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines. International Journal of Molecular Sciences. 21(19). 7333–7333. 4 indexed citations
13.
Pentimalli, Francesca, Sandro Grelli, Nicola Di Daniele, Gerry Melino, & Ivano Amelio. (2018). Cell death pathologies: targeting death pathways and the immune system for cancer therapy. Genes and Immunity. 20(7). 539–554. 46 indexed citations
14.
Alfano, Luigi, Iris Maria Forte, Carmelina Antonella Iannuzzi, et al.. (2017). NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer. Journal of Cellular Physiology. 233(5). 4338–4344. 14 indexed citations
15.
Cimini, Annamaria, Michele d’Angelo, Elisabetta Benedetti, et al.. (2016). Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs. Journal of Cellular Physiology. 232(2). 312–322. 21 indexed citations
16.
Fiore, Riccardo Di, Rosa Drago‐Ferrante, Francesca Pentimalli, et al.. (2014). MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells. International Journal of Oncology. 45(5). 2013–2023. 55 indexed citations
17.
Visconti, Roberta, Antonella Federico, Valeria Coppola, et al.. (2007). Transcriptional Profile of Ki-Ras-Induced Transformation of Thyroid Cells. Cancer Investigation. 25(4). 256–266. 4 indexed citations
18.
Fedele, Monica, Sabrina Battista, Francesca Pentimalli, et al.. (2004). Identification of the Genes Up- and Down-Regulated by the High Mobility Group A1 (HMGA1) Proteins. Cancer Research. 64(16). 5728–5735. 40 indexed citations
19.
Collins, Barbara, Gennaro Chiappetta, Arthur B. Schneider, et al.. (2002). RET Expression in Papillary Thyroid Cancer from Patients Irradiated in Childhood for Benign Conditions. The Journal of Clinical Endocrinology & Metabolism. 87(8). 3941–3946. 48 indexed citations
20.
Chiappetta, Gennaro, Paolo Toti, Francesco Cetta, et al.. (2002). TheRET/PTCOncogene Is Frequently Activated in Oncocytic Thyroid Tumors (Hurthle Cell Adenomas and Carcinomas), but Not in Oncocytic Hyperplastic Lesions. The Journal of Clinical Endocrinology & Metabolism. 87(1). 364–369. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026